eClinical news brief

By staff reporter

- Last updated on GMT

Related tags: Almac clinical technologies, Clinical trials, Clinical trial

Outsourcing-Pharma tracks the latest eClinical movements, featuring
Perceptive Informatics, Almac Clinical Technologies, Aptuit, INC
Research and OmniComm Systems.

Parexel's Perceptive Informatics​ has recently released an updated version of its comprehensive clinical trial management system (CTMS), Impact, which it says has improved site management and monitoring capabilities. The new version features an online and offline web-based site management and monitoring module, called MySites, which offers non-stop access from anywhere in the world, the company said. These additions were made in response to clients facing "further globalisation of clinical trials" and requiring "site management and monitoring of increasingly complex studies". Meanwhile, Almac Clinical Technologies​ has launched IXR Express, an interactive voice response system (IVRS) designed to help accelerate the clinical trial process. The firm said the IVRS was not a one size fits all application, but a "flexible solution created to meet the functional needs of a larger percentage of clinical trials than the standard configurable offerings currently on the market". "IXR Express has been created to meet the needs of simple to moderately complex trials and provides users the option of managing activities over the phone, the web or both". Likewise, contract research organisation (CRO) Aptuit​ also recently announced the availability of its new IVRS, which it claims provides users with "unparalleled functionality both over the phone and on the web… based on deployment speed, powerful reporting capability, and broad functionality in managing various aspects of clinical supply packaging, labelling, and distribution". The system is powered by US eclinical firm Clarix, whom Aptuit has also made a minority investment in and named one of the members to the Clarix board of directors. In other announcements, INC Research​ has formed a partnership with TheraSim to provide a web-based clinical performance management (CPM) system to assess the skills and behavior of clinicians for training purposes. TheraSim said it has designed its technology to assess site competency, correct deficiencies in good clinical practice (GCP), good laboratory practice (GLP) and protocol adherence; and uses patient simulation, remote adaptive learning and artificial intelligence technologies to track performance levels over time, of those who are managing clinical trials. INC said it "recognises the need to implement a comprehensive process for developing sites and improving outcomes" and initially plans on implementing the CPM system for investigator site training, "which is critical to the clinical trial process and currently lacks a global standard for training and development". Similarly, electronic data capture (EDC) firm OmniComm Systems​ is now partnering with Pharmatech, a Research Management Organisation (RMO), to build a patient registry database intended to improve patient accrual in clinical trials. The database will use the data mining functionality in OmniComm's TrialMaster EDC solution to allow the screening and identification of patients with the potential to participate in oncology studies. "This will be the first of its kind solution between a CRO and an EDC company that focuses on the problem of patient accrual", said Cornelis Wit, CEO of OmniComm.

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us


View more